Alejandro Romero Martínez (Alejandro Romero)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 29

Top Venues

Antioxidants (Basel, Switzerland)

Pharmaceutics

ACS chemical neuroscience

Chemical research in toxicology

Universidad Complutense de Madrid Facultad de Veterinaria

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Complutense de Madrid Facultad de Veterinaria Jun 12 2015

Spain

Profesor Contratado Doctor Interino :: Farmacología y Toxicologia

Publications

Alejandra Palomino-Antolín, Céline Decouty-Pérez, Víctor Farré-Alins, Paloma Narros-Fernández, Ana Belen Lopez-Rodriguez, María Álvarez-Rubal, Inés Valencia, Francisco López Muñoz, Eva Ramos, Antonio Cuadrado, Ana I Casas, Alejandro Romero Martínez, Javier Egea
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4. Antioxidants (Basel, Switzerland) 12 (9) (2023)
Victoria Jiménez Carretero, Eva Ramos, Pedro Segura-Chama, Adan Hernández, Andrés M Baraibar, Iris Álvarez-Merz, Francisco López Muñoz, Javier Egea, José M Solís, Alejandro Romero Martínez, Jesús M Hernández-Guijo
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging. Antioxidants (Basel, Switzerland) 12 (10) (2023)
Eva Ramos, Javier Egea, Francisco López Muñoz, Emilio Gil-Martín, Alejandro Romero Martínez
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review. Pharmaceutics 15 (6) (2023)
Eva Ramos, Emilio Gil-Martín, Cristóbal de Los Ríos, Javier Egea, Francisco López Muñoz, René Pita, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano, Russel Joseph Reiter, Alejandro Romero Martínez
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Eva Ramos, Javier Egea, Francisco López Muñoz, Emilio Gil-Martín, Alejandro Romero Martínez
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review. Pharmaceutics 15 (6) (2023)
Eva Ramos, Emilio Gil-Martín, Cristóbal de Los Ríos, Javier Egea, Francisco López Muñoz, René Pita, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano, Russel Joseph Reiter, Alejandro Romero Martínez
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Eva Ramos, Emilio Gil-Martín, Cristóbal de Los Ríos, Javier Egea, Francisco López Muñoz, René Pita, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano, Russel Joseph Reiter, Alejandro Romero Martínez
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Russel Joseph Reiter, Ramaswamy Sharma, Alejandro Romero Martínez, Walter Manucha, Dun-Xian Tan, Debora Aparecida Pires de Campos Aparecida Pires de Campos Zuccari, Luiz Gustavo de Almeida Gustavo de Almeida Chuffa
Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Russel Joseph Reiter, Ramaswamy Sharma, Alejandro Romero Martínez, Walter Manucha, Dun-Xian Tan, Debora Aparecida Pires de Campos Aparecida Pires de Campos Zuccari, Luiz Gustavo de Almeida Gustavo de Almeida Chuffa
Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Marta Rodríguez-Torrado, Aytug Kara, Susana Torrado, Alejandro Romero Martínez, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano
In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration. Pharmaceutics 14 (12) (2022)
Marta Rodríguez-Torrado, Aytug Kara, Susana Torrado, Alejandro Romero Martínez, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano
In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration. Pharmaceutics 14 (12) (2022)
Paloma Narros-Fernández, Mourad Chioua, Sonia A Petcu, Daniel Diez-Iriepa, Laura Cerrada-Gálvez, Céline Decouty-Pérez, Alejandra Palomino-Antolín, Eva Ramos, Víctor Farré-Alins, Ana Belén López-Rodríguez, Alejandro Romero Martínez, José Marco-Contelles, Javier Egea
Synthesis and Pharmacological Evaluation of New N -Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout. Journal of medicinal chemistry 65 (8) (2022)
Marta Rodríguez-Torrado, Aytug Kara, Susana Torrado, Alejandro Romero Martínez, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano
In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration. Pharmaceutics 14 (12) (2022)
Marta Rodríguez-Torrado, Aytug Kara, Susana Torrado, Alejandro Romero Martínez, Antonio Juberías, Juan José Torrado, Dolores Remedios Serrano
In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration. Pharmaceutics 14 (12) (2022)
Eva Ramos, Francisco López Muñoz, Emilio Gil-Martín, Javier Egea, Iris Álvarez-Merz, Sakshi Painuli, Prabhakar Semwal, Natália Cruz Martins, Jesús M Hernández-Guijo, Alejandro Romero Martínez
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants (Basel, Switzerland) 10 (7) (2021)
Alejandro Romero Martínez, Eva Ramos, Francisco López Muñoz, Cristóbal de Los Ríos, Javier Egea, Emilio Gil-Martín, René Pita, Juan J Torrado, Dolores Remedios Serrano, Antonio Juberias
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? Diseases (Basel, Switzerland) 9 (2) (2021)
Eva Ramos, Rocío Lajarín-Cuesta, Raquel L Arribas, Eva M García-Frutos, Laura González-Lafuente, Javier Egea, Cristóbal de Los Ríos, Alejandro Romero Martínez
In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral N-Propargyl-1,2-amino Alcohol Derivatives. Chemical research in toxicology 34 (5) (2021)
Anna Więckowska, Natalia Szałaj, Izabella Góral, Adam Bucki, Gniewomir Latacz, Katarzyna Kiec-Kononowicz, Òscar M Bautista-Aguilera, Alejandro Romero Martínez, Eva Ramos, Javier Egea, Victor Farré Alíns, Águeda González-Rodríguez, Francisco López-Muñoz, Mourad Chioua, José Marco-Contelles
In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. ACS chemical neuroscience 11 (22) (2020)
Víctor Farré-Alins, Paloma Narros-Fernández, Alejandra Palomino-Antolín, Céline Decouty-Pérez, Ana Belen Lopez-Rodriguez, Esther Parada, Alicia Muñoz-Montero, Vanessa Gómez-Rangel, Francisco López Muñoz, Eva Ramos, Águeda González-Rodríguez, Luis Gandía, Alejandro Romero Martínez, Javier Egea
Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux. Antioxidants (Basel, Switzerland) 9 (12) (2020)
Emilio Gil-Martín, Francisco López-Muñoz, Russel J Reiter, Alejandro Romero Martínez
Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy. Future medicinal chemistry 12 (13) (2020)
Martín Estrada-Valencia, Clara Herrera-Arozamena, Concepción Pérez, Dolores Viña, Jose Ángel Morales-García, Ana Pérez-Castillo, Eva Ramos, Alejandro Romero Martínez, Erik Laurini, Sabrina Pricl, María Isabel Rodríguez-Franco
New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2020)
Alejandro Romero Martínez, Eva Ramos, Francisco López Muñoz, Emilio Gil-Martín, Germaine Escames, Russel Joseph Reiter
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin? Cellular and molecular neurobiology (2020)
Eva Ramos, Alejandra Palomino-Antolín, Manuela Bartolini, Isabel Iriepa, Ignacio Moraleda, Daniel Diez-Iriepa, Abdelouahid Samadi, Carol V Cortina, Mourad Chioua, Javier Egea, Alejandro Romero Martínez, José Marco-Contelles
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy. Molecules (Basel, Switzerland) 24 (8) (2019)
Emilio Gil-Martín, Javier Egea, Russel J Reiter, Alejandro Romero Martínez
The emergence of melatonin in oncology: Focus on colorectal cancer. Medicinal research reviews 39 (6) (2019)
Eva Ramos, Alejandro Romero Martínez, José Marco-Contelles, Francisco López-Muñoz, Javier Del Pino
Modulation of Heat Shock Response Proteins by ASS234, Targeted for Neurodegenerative Diseases Therapy. Chemical research in toxicology 31 (9) (2018)
Francisco López Muñoz, Winston W Shen, Pilar D'Ocon, Alejandro Romero Martínez, Cecilio Álamo
A History of the Pharmacological Treatment of Bipolar Disorder. International journal of molecular sciences 19 (7) (2018)
Eva Ramos, José Marco-Contelles, Francisco López-Muñoz, Alejandro Romero Martínez
In silico assessment of the metabolism and its safety significance of multitarget propargylamine ASS234. CNS neuroscience & therapeutics 24 (10) (2018)
Javier Del Pino, José Marco-Contelles, Francisco López-Muñoz, Alejandro Romero Martínez, Eva Ramos
Neuroinflammation Signaling Modulated by ASS234, a Multitarget Small Molecule for Alzheimer's Disease Therapy. ACS chemical neuroscience 9 (12) (2018)
Óscar M Bautista-Aguilera, Stefanie Hagenow, Alejandra Palomino-Antolin, Víctor Farré-Alins, Lhassane Ismaili, Pierre-Louis Joffrin, M Luisa Jimeno, Ondrej Soukup, Jana Janočková, Lena Kalinowsky, Ewgenij Proschak, Isabel Iriepa, Ignacio Moraleda, Johannes S Schwed, Alejandro Romero Martínez, Francisco López-Muñoz, Mourad Chioua, Javier Egea, Rona R Ramsay, José Marco-Contelles, Holger Stark
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases. Angewandte Chemie (International ed. in English) 56 (41) (2017)

Alejandro Romero Martínez.css-eqlu8i{font-size:small;padding-left:4px;} (Alejandro Romero)

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandro Romero Martínez (Alejandro Romero)